Chronic myelomonocytic leukemia in younger patients: Molecular and cytogenetic predictors of survival and treatment outcome

M. M. Patnaik; E. A. Wassie; E. Padron; F. Onida; R. Itzykson; T. L. Lasho; O. Kosmider; C. M. Finke; C. A. Hanson; R. P. Ketterling; R. Komrokji; A. Tefferi; E. Solary

doi:10.1038/bcj.2014.90

Chronic myelomonocytic leukemia in younger patients: Molecular and cytogenetic predictors of survival and treatment outcome

M. M. Patnaik, E. A. Wassie, E. Padron, F. Onida, R. Itzykson, T. L. Lasho, O. Kosmider, C. M. Finke, C. A. Hanson, R. P. Ketterling, R. Komrokji, A. Tefferi, E. Solary

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article › peer-review

Abstract

In patients with chronic myelomonocytic leukemia (CMML), age >65 years is an adverse prognostic factor. Our objective in the current study was to examine risk factors for survival and treatment outcome in 261 'young' adults with CMML, as defined by age

Original language	English
Pages (from-to)	e270
Journal	Blood Cancer Journal
Volume	5
Issue number	1
DOIs	https://doi.org/10.1038/bcj.2014.90
Publication status	Published - Jan 1 2015

ASJC Scopus subject areas

Oncology
Hematology
Medicine(all)

Access to Document

10.1038/bcj.2014.90

Cite this

Patnaik, M. M., Wassie, E. A., Padron, E., Onida, F., Itzykson, R., Lasho, T. L., Kosmider, O., Finke, C. M., Hanson, C. A., Ketterling, R. P., Komrokji, R., Tefferi, A., & Solary, E. (2015). Chronic myelomonocytic leukemia in younger patients: Molecular and cytogenetic predictors of survival and treatment outcome. Blood Cancer Journal, 5(1), e270. https://doi.org/10.1038/bcj.2014.90

Chronic myelomonocytic leukemia in younger patients : Molecular and cytogenetic predictors of survival and treatment outcome. / Patnaik, M. M.; Wassie, E. A.; Padron, E.; Onida, F.; Itzykson, R.; Lasho, T. L.; Kosmider, O.; Finke, C. M.; Hanson, C. A.; Ketterling, R. P.; Komrokji, R.; Tefferi, A.; Solary, E.

In: Blood Cancer Journal, Vol. 5, No. 1, 01.01.2015, p. e270.

Research output: Contribution to journal › Article › peer-review

Patnaik, MM, Wassie, EA, Padron, E, Onida, F, Itzykson, R, Lasho, TL, Kosmider, O, Finke, CM, Hanson, CA, Ketterling, RP, Komrokji, R, Tefferi, A & Solary, E 2015, 'Chronic myelomonocytic leukemia in younger patients: Molecular and cytogenetic predictors of survival and treatment outcome', Blood Cancer Journal, vol. 5, no. 1, pp. e270. https://doi.org/10.1038/bcj.2014.90

Patnaik, M. M. ; Wassie, E. A. ; Padron, E. ; Onida, F. ; Itzykson, R. ; Lasho, T. L. ; Kosmider, O. ; Finke, C. M. ; Hanson, C. A. ; Ketterling, R. P. ; Komrokji, R. ; Tefferi, A. ; Solary, E. / Chronic myelomonocytic leukemia in younger patients : Molecular and cytogenetic predictors of survival and treatment outcome. In: Blood Cancer Journal. 2015 ; Vol. 5, No. 1. pp. e270.

@article{3b51ac365c0a4d73a0f396708b38eaaf,

title = "Chronic myelomonocytic leukemia in younger patients: Molecular and cytogenetic predictors of survival and treatment outcome",

abstract = "In patients with chronic myelomonocytic leukemia (CMML), age >65 years is an adverse prognostic factor. Our objective in the current study was to examine risk factors for survival and treatment outcome in 261 'young' adults with CMML, as defined by age",

author = "Patnaik, {M. M.} and Wassie, {E. A.} and E. Padron and F. Onida and R. Itzykson and Lasho, {T. L.} and O. Kosmider and Finke, {C. M.} and Hanson, {C. A.} and Ketterling, {R. P.} and R. Komrokji and A. Tefferi and E. Solary",

year = "2015",

month = jan,

day = "1",

doi = "10.1038/bcj.2014.90",

language = "English",

volume = "5",

pages = "e270",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Chronic myelomonocytic leukemia in younger patients

T2 - Molecular and cytogenetic predictors of survival and treatment outcome

AU - Patnaik, M. M.

AU - Wassie, E. A.

AU - Padron, E.

AU - Onida, F.

AU - Itzykson, R.

AU - Lasho, T. L.

AU - Kosmider, O.

AU - Finke, C. M.

AU - Hanson, C. A.

AU - Ketterling, R. P.

AU - Komrokji, R.

AU - Tefferi, A.

AU - Solary, E.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - In patients with chronic myelomonocytic leukemia (CMML), age >65 years is an adverse prognostic factor. Our objective in the current study was to examine risk factors for survival and treatment outcome in 261 'young' adults with CMML, as defined by age

AB - In patients with chronic myelomonocytic leukemia (CMML), age >65 years is an adverse prognostic factor. Our objective in the current study was to examine risk factors for survival and treatment outcome in 261 'young' adults with CMML, as defined by age

UR - http://www.scopus.com/inward/record.url?scp=84927745746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927745746&partnerID=8YFLogxK

U2 - 10.1038/bcj.2014.90

DO - 10.1038/bcj.2014.90

M3 - Article

C2 - 25555161

AN - SCOPUS:84927745746

VL - 5

SP - e270

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 1

ER -

Chronic myelomonocytic leukemia in younger patients: Molecular and cytogenetic predictors of survival and treatment outcome

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this